This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comparative Study

. 2005 Dec;46(12):1405-8.

doi: 10.1007/s00108-005-1510-x.

[ASS or clopidogrel plus esomeprazole after bleeding from an ulcer]

[Article in German]

S Nitschmann¹, J Mössner

Affiliations

PMID: 16220275
DOI: 10.1007/s00108-005-1510-x

Comparative Study

[ASS or clopidogrel plus esomeprazole after bleeding from an ulcer]

[Article in German]

S Nitschmann et al. Internist (Berl). 2005 Dec.

. 2005 Dec;46(12):1405-8.

doi: 10.1007/s00108-005-1510-x.

Authors

S Nitschmann¹, J Mössner

Affiliation

¹ Fridinger Strasse 16a, 70619 Stuttgart. nitschmann@gmx.de

PMID: 16220275
DOI: 10.1007/s00108-005-1510-x

No abstract available

PubMed Disclaimer

Similar articles

Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding.
Chan FK, Ching JY, Hung LC, Wong VW, Leung VK, Kung NN, Hui AJ, Wu JC, Leung WK, Lee VW, Lee KK, Lee YT, Lau JY, To KF, Chan HL, Chung SC, Sung JJ. Chan FK, et al. N Engl J Med. 2005 Jan 20;352(3):238-44. doi: 10.1056/NEJMoa042087. N Engl J Med. 2005. PMID: 15659723 Clinical Trial.
Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
Wolk MJ, Jacobs AK. Wolk MJ, et al. N Engl J Med. 2005 Apr 21;352(16):1716-8; author reply 1716-8. doi: 10.1056/NEJM200504213521617. N Engl J Med. 2005. PMID: 15843675 No abstract available.
Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.
Wargo KA, Baty SR, Knowles G. Wargo KA, et al. N Engl J Med. 2005 Apr 21;352(16):1716-8; author reply 1716-8. N Engl J Med. 2005. PMID: 15846858 No abstract available.
[Dilemma between gastroprotection and cardiovascular prevention].
Venerito M, Kandulski A, Malfertheiner P. Venerito M, et al. Dtsch Med Wochenschr. 2010 Nov;135(44):2193-8. doi: 10.1055/s-0030-1267498. Epub 2010 Oct 26. Dtsch Med Wochenschr. 2010. PMID: 20979006 Review. German.
[Antiplatelet agents and proton pump inhibitors. How can the risk-benefit balance be optimized in patients at risk for cardiovascular disease and gastrointestinal bleeding?].
Casado-Arroyo R, Muñoz-Villalenguas M, Lanas Arbeloa A. Casado-Arroyo R, et al. Gastroenterol Hepatol. 2011 Aug-Sep;34(7):478-91. doi: 10.1016/j.gastrohep.2011.04.002. Epub 2011 Jun 17. Gastroenterol Hepatol. 2011. PMID: 21684042 Review. Spanish.

See all similar articles

References

1. N Engl J Med. 2005 Jan 20;352(3):238-44 - PubMed
1. Lancet. 2002 Jan 5;359(9300):9-13 - PubMed
1. N Engl J Med. 1998 Mar 12;338(11):727-34 - PubMed
1. N Engl J Med. 1998 Mar 12;338(11):719-26 - PubMed
1. Gastroenterology. 2004 Oct;127(4):1038-43 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer
Miscellaneous
- NCI CPTAC Assay Portal